Global Bioenergies

GLOBAL BIOENERGIES: €3.1 million from ADEME to move forward on the IBN-One plant project

Retrieved on: 
Wednesday, October 2, 2019

We have been witnessing a growing demand in the field of cosmetics for natural ingredients.

Key Points: 
  • We have been witnessing a growing demand in the field of cosmetics for natural ingredients.
  • The plant's business plan is now focused on this field, and displays a very high profitability.
  • Marc Delcourt, CEO of Global Bioenergies, concluded: "Financing a first of its kind plant, based on an innovative technology is always a challenge.
  • Global Bioenergies continues to improve the performance of its process, conducts trials on its demo plant in Germany and is preparing the first full-sized plant in a JointVenture with Cristal Union.

Global Bioenergies: changes to the Board of Directors

Retrieved on: 
Thursday, September 5, 2019

Moreover, the venture capital company Seventure Partners, historically speaking the first investor in Global Bioenergies, has resigned from its functions as Company director, effective today.

Key Points: 
  • Moreover, the venture capital company Seventure Partners, historically speaking the first investor in Global Bioenergies, has resigned from its functions as Company director, effective today.
  • John Pierce, Chairman of the board of Global Bioenergies, said: "Huge thanks to Seventure for their unfailing support over the past ten years, and welcome to L'Oral as we start writing this new chapter.
  • Global Bioenergies continues to improve the performance of its process, conducts trials on its demo plant in Germany and is preparing the first full-sized plant in a JointVenture with Cristal Union.
  • Global Bioenergies is listed on Euronext Growth in Paris (FR0011052257 ALGBE).

Global Bioenergies Receives Letters of Intent for Purchases Covering the Capacity of its First Plant Project, IBN-One, a Joint Venture with Cristal Union

Retrieved on: 
Tuesday, November 27, 2018

Over half of the letters of intent and a significant share of capacity (about 20%) are earmarked for high added-value niche markets in specialty fuels and cosmetics.

Key Points: 
  • Over half of the letters of intent and a significant share of capacity (about 20%) are earmarked for high added-value niche markets in specialty fuels and cosmetics.
  • Several of the letters of intent include price indications that confirm the potential for isobutene derivatives to fetch prices far higher than their oil-derived counterparts.
  • We estimate the global market for isobutene derivatives in tens of thousands of tons per year, just for cosmetics.
  • Global Bioenergies pursues the improvement of its process, operates a demo plant in Germany and prepares the first full-scale plant through a joint venture with Cristal Union, named IBN-One.

Global Bioenergies to Attend the Goldman Sachs Sustainable Finance Innovation Forum

Retrieved on: 
Wednesday, November 7, 2018

NEW YORK and EVRY, France, Nov. 7, 2018 /PRNewswire/ --Global Bioenergies (Euronext Growth: ALGBE) a leader in industrial biotechnology developing a process to convert renewable resources into hydrocarbons through fermentation, will be attending the Goldman Sachs Sustainable Finance Innovation Forum.

Key Points: 
  • NEW YORK and EVRY, France, Nov. 7, 2018 /PRNewswire/ --Global Bioenergies (Euronext Growth: ALGBE) a leader in industrial biotechnology developing a process to convert renewable resources into hydrocarbons through fermentation, will be attending the Goldman Sachs Sustainable Finance Innovation Forum.
  • Marc Delcourt, Chief Executive Officer of Global Bioenergies, will be conducting one-on-one meetings with investors surrounding the event.
  • Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation.
  • Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 ALGBE).

Global Bioenergies to Present at Lytham Partners Virtual Investor Conference

Retrieved on: 
Wednesday, October 24, 2018

A replay of the presentation will be available on demand following the conclusion of the live event.

Key Points: 
  • A replay of the presentation will be available on demand following the conclusion of the live event.
  • Global Bioenergies is one of the few companies worldwide, and the only one in Europe, that is developing a process to convert renewable resources into hydrocarbons through fermentation.
  • Global Bioenergies continues to improve the performance of its process, to operate its demo plant in Germany, and to prepare the first full- scale plant through a joint venture with Cristal Union, named IBN-One.
  • Global Bioenergies is listed on Euronext Growth Paris (FR0011052257 ALGBE).